Skip to content
Forschung

A Systematic Review of Craniosacral Therapy: Biological Plausibility, Assessment Reliability, and Clinical Effectiveness

British Columbia Office of Health Technology Assessment (BCOHTA) systematic review. Searched Medline, Embase, Healthstar, Mantis, Allied and Alternative Medicine, Scisearch, and Biosis from start to February 1999. Found low-grade evidence with inadequate research protocols. One study reported negative side effects in traumatic brain injury patients. Low inter-rater reliability ratings.

2026-03-25

When a health technology assessment office reviews a therapy properly, it doesn't only ask whether trials show an effect. It also asks: is there a plausible mechanism? And: can practitioners reliably reproduce assessments on the same patient? Three different questions. The British Columbia Office of Health Technology Assessment (BCOHTA) asked all three of craniosacral therapy.

This matters for CST because the three questions get different answers. Looking at each one on its own gives you a more honest picture than a single verdict like "the evidence is weak" or "people find it helpful."

The BCOHTA review searched Medline, Embase and other databases, drawing on a sizable literature. What it found on each question tells you something different about where CST sits scientifically.

Biological plausibility and mechanism

Plausibility asks whether the proposed mechanism is anatomically and physiologically possible. The core CST claims — that adult cranial bones are mobile, that cerebrospinal fluid has a palpable rhythm distinct from heartbeat and breath, and that 5–10 grams of touch can affect those systems — each carry specific anatomical implications.

The BCOHTA review looked at the anatomy carefully. Adult cranial sutures are largely, but not entirely, fused. The degree varies by suture, by person, and by age. Whether any leftover mobility is enough to matter clinically, or to be felt through light touch, is contested. The review judged the evidence for this part of the model to be weak.

On the rhythm itself, the review found that an independent craniosacral rhythm — separate from heartbeat and respiration — has not been established. Some studies have tried to measure it directly. Results have been inconsistent and methodologically contested. Plausibility is genuinely uncertain, not definitively disproven.

Reliability between practitioners

Reliability is a different question from plausibility. Even if a craniosacral rhythm exists in some form, you'd only have a consistent clinical practice if practitioners could reliably perceive the same thing in the same patient. As the 1994 interrater reliability study showed — and the BCOHTA review noted — the evidence isn't encouraging.

Multiple studies looking at interrater reliability for CST assessments have produced similarly disappointing results. When practitioners assess the same patients independently, agreement on rate, timing, and the quality of the rhythm is consistently low. That's a separate problem from whether the rhythm exists. Even if it does, practitioners may not be detecting it consistently.

The BCOHTA review treated this as a serious finding for the theory. If assessment is unreliable, claims that treatment is precisely targeted to specific findings get harder to defend. Some practitioners, faced with this, argue that CST's value lies less in specific diagnosis and more in the quality of contact and presence. That sidesteps the reliability problem but needs a different theoretical frame.

What the clinical evidence shows

On effectiveness, the BCOHTA review found a mixed and limited picture. Some studies showed positive effects, mostly in pain conditions. Others found no difference from control. Overall evidence quality was rated low, reflecting the methodological problems that keep showing up in CST research: blinding, small samples, varied populations and protocols.

This lines up with what later, larger reviews have found. The evidence is thin. Not definitively negative, but not strong enough to support confident clinical recommendations for specific conditions. That sits differently for different people. A clinician making treatment recommendations needs stronger evidence than someone exploring their own options.

The value of the BCOHTA's three-question setup is that it stops you from blurring these things together. You can think the mechanism is theoretically weak, that practitioner reliability is poor, and that the clinical evidence is insufficient — and still think some people get real benefit from CST sessions, that the work is low-risk, and that individual experience is a fair basis for an informed decision. Those positions don't contradict each other.

The BCOHTA review remains one of the more thorough assessments of CST because it kept the mechanism, reliability and effectiveness questions separate. Each has its own answer, and reading them one at a time gives a more honest picture than any single verdict.